3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
4
Infections
3
Thyroid Nodule
2
Neoplasms, Plasma Cell
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia
2
Febrile Neutropenia
2
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Sepsis
1
Respiratory Sounds
1
Prostatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Glioblastoma
1
Emergencies
1
Diverticulitis
1
Cystectomy
1
Brain Neoplasms
1
Astrocytoma
1
Asthma
1
Interventions
Beclomethasone
2
perflutren
1
Surveys and Questionnaires
1
Sulfur Hexafluoride
1
Spirometry
1
Prednisolone
1
Lysine Acetyltransferase 5
1
Helium
1
Health Information Exchange
1
Fractional Exhaled Nitric Oxide Testing
1
Exercise
1
Etanercept
1
Escitalopram
1
Cari-D-Tect
1
Budesonide
1
Bronchial Thermoplasty
1
Blood Specimen Collection
1
Azithromycin
1
Amoxicillin-Potassium Clavulanate Combination
1
Albuterol
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Asthma
×
Amoxicillin-Potassium Clavulanate Combination
×
Clear all
NCT02517099
2023-03-06
PrIGMa
Imperial College London
Phase 2
Completed
60 enrolled
10 charts